StockData

Jaguar Health vs Sunshine Biopharma

JAGX and SBFM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How JAGX and SBFM compare

Jaguar Health is the larger company, worth 3.1 times as much as Sunshine Biopharma ($2.5M against $790K).

Jaguar Health grew revenue faster over the last twelve months (136% versus −5.2% for Sunshine Biopharma).

Sunshine Biopharma scores higher on the StockData Score (12 against 3 for Jaguar Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricJAGXSBFM
Size and price
Market cap$2.5M$790K
Share price$0.480$2.84
Change, 1 year−99.9%−99.2%
Change, 5 years−100%−76.3%
Beta (5Y)2.21–
Employees4750
StockData Score
Total score312 (better)
Valuation score13 (better)
Growth score2 (better)1
Performance score03 (better)
Health score05 (better)
Dividend score00
Valuation
P/S0.1×0.0× (better)
P/B–0.0×
Fair value–$213.99
Margin of safety–98.7%
Growth
Revenue growth (TTM)136% (better)−5.2%
Revenue growth, 5Y average4.2%248% (better)
Profitability
Gross margin82.3% (better)30.4%
Operating margin−93.1%−17.2% (better)
Net margin–−17.5%
Return on equity–−23.4%
Return on invested capital–−33.3%
Financial health
Debt / equity–0.00
Interest coverage−25.9×–
Current ratio0.696.47 (better)
Altman Z-score−18.44−1.80 (better)
Piotroski F-score24 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions–28.9%
Held by insiders17.1%24.5%
Short interest, % of float4.7%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.